FDA — authorised 6 April 2021
- Application: BLA125084
- Marketing authorisation holder: IMCLONE
- Indication: Efficacy
- Status: approved
🇺🇸 Erbitux in United States
FDA authorised Erbitux on 6 April 2021
Marketing authorisation
Erbitux in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Erbitux approved in United States?
Yes. FDA authorised it on 6 April 2021.
Who is the marketing authorisation holder for Erbitux in United States?
IMCLONE holds the US marketing authorisation.